![Matthew Lehman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Lehman
Director Ejecutivo en
Koligo Therapeutics, Inc.
.
Perfil
Matthew B. Lehman is currently Chief Executive Officer at Koligo Therapeutics, Inc., and a member of the Association of Clinical Research Professionals and the European Business Association.
Formerly, Mr. Lehman was President, Chief Executive Officer & Director at Callitas Health, Inc. from 2015 to 2016; Chief Executive Officer, MD & Executive Director at Immutep Ltd. from 2013 to 2014; Chief Executive Officer & Executive Director at Koligo Therapeutics Ltd.; and Chief Operating Officer at SPRI Clinical Trials-Global LLC.
Education includes graduate studies at The Trustees of Columbia University in The City of New York and undergraduate studies at the University of Louisville.
Cargos activos de Matthew Lehman
| Empresas | Cargo | Inicio |
|---|---|---|
European Business Association | Corporate Officer/Principal | 03/01/2011 |
Association of Clinical Research Professionals
 Association of Clinical Research Professionals Miscellaneous Commercial ServicesCommercial Services Operates as a association of clinical research professionals | Corporate Officer/Principal | 03/01/2011 |
Koligo Therapeutics, Inc.
 Koligo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes transformative cell therapies for the treatment of pancreatic diseases | Director Ejecutivo | - |
Antiguos cargos conocidos de Matthew Lehman.
| Empresas | Cargo | Fin |
|---|---|---|
Koligo Therapeutics Ltd.
 Koligo Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops, manufacture, and sells transformative cell therapies for the treatment of pancreatic diseases | Director Ejecutivo | 18/02/2021 |
| CALLITAS HEALTH INC. | Director Ejecutivo | 15/03/2016 |
| IMMUTEP LIMITED | Director Ejecutivo | 09/07/2014 |
SPRI Clinical Trials-Global LLC
 SPRI Clinical Trials-Global LLC Miscellaneous Commercial ServicesCommercial Services Engages in clinical research | Director de Operaciones | - |
Formación de Matthew Lehman.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
67
Relaciones de 1er grado
9
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 9 |
|---|---|
Callitas Health, Inc.
 Callitas Health, Inc. Pharmaceuticals: MajorHealth Technology Develops technologies for monitoring and treatment of obesity, diabetes & other gastroenterological indications | Health Technology |
SPRI Clinical Trials-Global LLC
SPRI Clinical Trials-Global LLC Miscellaneous Commercial ServicesCommercial Services Engages in clinical research | Commercial Services |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immutep Ltd.
 Immutep Ltd. BiotechnologyHealth Technology Engages in the development of anti-cancer therapeutics | Health Technology |
University of Louisville
 University of Louisville Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Association of Clinical Research Professionals
Association of Clinical Research Professionals Miscellaneous Commercial ServicesCommercial Services Operates as a association of clinical research professionals | Commercial Services |
European Business Association | |
Koligo Therapeutics, Inc.
Koligo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes transformative cell therapies for the treatment of pancreatic diseases | Health Technology |
Koligo Therapeutics Ltd.
Koligo Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops, manufacture, and sells transformative cell therapies for the treatment of pancreatic diseases | Health Technology |
- Bolsa de valores
- Insiders
- Matthew Lehman
